Metropolis Healthcare Limited — Investor Meet, 02-09-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Metropolis Healthcare reported FY26 revenue of INR 1,646 Cr, with Q1 showing 17% growth. Management aims for 27-28% EBITDA margins (from 24.4%) driven by increased volumes and asset utilization. Strategic levers include expanding its 5,000+ center network, growing its TruHealth wellness packages (now 20% of business), and increasing high-margin specialty testing (40% of revenue, with 400 new tests added). Digital channels contribute 25% of business. New ventures include 100 mini-radiology hubs and exploring allied healthcare services in owned centers. The company maintains a disciplined acquisition approach, focusing on clean businesses. North India is a growth focus, targeting 25% contribution. Management expressed confidence in continued accelerated growth.